September 2, 2009 – Volcano Corp. said this week it entered into a nonexclusive, global resale agreement with ...
Intravascular Imaging
This channel includes news and new technology innovations for intra-vascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging systems used in the cath lab. These imaging modalities help with diagnostic decisions about how to treat atheroscolosis and help guide device placement and verification of stent apposition. The technology also is used to visualize in-stent restenosis.
August 21, 2009 – The Cardiovascular Rearch Foundation, the sponsor of the Transcatheter Cardiovascular ...
July 9, 2009 - Volcano Corporation said yesterday it signed a termination agreement with its largest distributor ...
June 1, 2009 - Six months after placement of a vProtect Luminal Shield to treat a "vulnerable plaque,” a follow ...
May 21, 2009 - LightLab Imaging Inc. this week is launching its next generation optical coherence tomography (OCT) ...
March 19, 2009 - Boston Scientific Corp. today announced the launch of its iCross Coronary Imaging Catheter, a ...
While angiography is the gold standard for vascular imaging in the cath lab, new intravascular imaging modalities ...
Intravascular ultrasound (IVUS) uses a tiny ultrasound transducer mounted on the tip of a catheter to image the ...
January 6, 2009 - LightLab Imaging Inc. said the number of clinical intravascular optical coherence tomography ...
December 30, 2008 - Volcano Corp. will acquire Axsun Technologies Inc., a developer and manufacturer of lasers and ...
December 23, 2008 - Volcano Corp., a manufacturer of products for the diagnosis and treatment of coronary and ...
December 23, 2008 - St. Jude Medical Inc. said this week it completed the acquisition of Radi Medical Systems AB ...
With the full integration of GE Healthcare's (GE) Innova system with Volcano's s5i IVUS system, there is no need to roll ...
There is considerable interest in being able to clearly identify vulnerable plaque (VP) and research efforts are ...
October 20, 2008 – At TCT last week Abbott announced two-year data from 30 patients in its ABSORB clinical trial ...